Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy National Health Investors (NHI) stocks in Canada

Learn how to easily invest in National Health Investors stocks.

National Health Investors is a reit-healthcare facilities business based in the US. National Health Investors stocks (NHI.US) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $66.42 – a decrease of 2.71% over the previous week. National Health Investors employs 19 staff and has a trailing 12-month revenue of around $306.9 million.

How to buy shares in National Health Investors

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – NHI – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

National Health Investors stock price (NYSE:NHI)

Use our graph to track the performance of NHI stocks over time.

National Health Investors shares at a glance

Information last updated 2022-01-25.
Latest market close$57.16
52-week range$50.09 - $73.95
50-day moving average $56.76
200-day moving average $61.98
Wall St. target price$60.67
PE ratio 13.764
Dividend yield $4.005 (6.13%)
Earnings per share (TTM) $3.13

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
Wealthsimple Trade
Finder Rating:
3.9 / 5
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
3.8 / 5
$4.99 - $9.99
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
4.1 / 5
Min. $1.00, Max. 0.5%
Stocks, Bonds, Options, ETFs, Currencies, Futures
CIBC Investor's Edge
Finder Rating:
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Finder Rating:
4.2 / 5
$4.95 - $9.95
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get up to $5,000 cash back. Conditions apply. Offer ends March 1, 2022.

Compare up to 4 providers

Online stock trading

Is it a good time to buy National Health Investors stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

National Health Investors price performance over time

Historical closes compared with the close of $57.16 from 2022-01-27

1 week (2022-01-21) -2.71%
1 month (2021-12-29) -0.97%
3 months (2021-10-29) 6.28%
6 months (2021-07-29) -15.87%
1 year (2021-01-29) -11.84%
2 years (2020-01-29) -33.14%
3 years (2019-01-29) 81.23
5 years (2017-01-27) 73.57

Is National Health Investors under- or over-valued?

Valuing National Health Investors stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of National Health Investors's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

National Health Investors's P/E ratio

National Health Investors's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 14x. In other words, National Health Investors shares trade at around 14x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

National Health Investors's PEG ratio

National Health Investors's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.99. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into National Health Investors's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

National Health Investors's EBITDA

National Health Investors's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $277.2 million.

The EBITDA is a measure of a National Health Investors's overall financial performance and is widely used to measure a its profitability.

National Health Investors financials

Revenue TTM $306.9 million
Operating margin TTM 63.43%
Gross profit TTM $320 million
Return on assets TTM 4.02%
Return on equity TTM 939.74%
Profit margin 46.42%
Book value $33.57
Market capitalisation $2.7 billion

TTM: trailing 12 months

National Health Investors share dividends


Dividend payout ratio: 77.44% of net profits

Recently National Health Investors has paid out, on average, around 77.44% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 6.13% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), National Health Investors shareholders could enjoy a 6.13% return on their shares, in the form of dividend payments. In National Health Investors's case, that would currently equate to about $4.005 per share.

National Health Investors's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.

National Health Investors's most recent dividend payout was on 30 January 2022. The latest dividend was paid out to all shareholders who bought their shares by 29 December 2021 (the "ex-dividend date").

National Health Investors share price volatility

Over the last 12 months, National Health Investors's shares have ranged in value from as little as $50.0866 up to $73.9539. A popular way to gauge a stock's volatility is its "beta".

NHI.US volatility(beta: 0.97)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while National Health Investors's is 0.9747. This would suggest that National Health Investors's shares are less volatile than average (for this exchange).

National Health Investors overview

Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals. .

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site